AllianceBernstein
NMRA icon

AllianceBernstein’s Neumora Therapeutics NMRA Stock Holding History

AllianceBernstein’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Buy
+110,100
New +$210K ﹤0.01% 3122
2025
Q2 		– Sell
-88,020
Closed -$88K – 3295
2025
Q1 		$88K Sell
88,020
-111,927
-56% -$192K ﹤0.01% 3081
2024
Q4 		$2.12M Sell
199,947
-22,930
-10% -$275K ﹤0.01% 1929
2024
Q3 		$2.94M Sell
222,877
-44,348
-17% -$517K ﹤0.01% 1766
2024
Q2 		$2.63M Buy
+267,225
New +$2.76M ﹤0.01% 1799

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

AllianceBernstein's NMRA Position: Q2 2026 in Review

AllianceBernstein opened a new position in Neumora Therapeutics (NMRA) in Q2 2026: 110,100 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #3122 among its holdings. This is a return to the name: AllianceBernstein previously reported a position in NMRA as recently as Q1 2025.

AllianceBernstein first reported a position in NMRA in Q2 2024 and has held it in 5 quarters since. The position peaked at $2.94M in Q3 2024. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • AllianceBernstein held 110,100 shares of Neumora Therapeutics worth $215K as of Q2 2026.
  • Neumora Therapeutics was a new AllianceBernstein position in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3122 holding.
  • AllianceBernstein first reported a position in Neumora Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • AllianceBernstein's Neumora Therapeutics position peaked at $2.94M in Q3 2024.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.